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The last two decades have seen a strong rise in empirical research in the mechanisms of emotion dysregulation in
borderline personality disorder. Major findings comprise structural as well as functional alterations of brain regions
involved in emotion processing, such as amygdala, insula, and prefrontal regions. In addition, more specific
mechanisms of disturbed emotion regulation, e.g. related to pain and dissociation, have been identified. Most
recently, social interaction problems and their underlying neurobiological mechanisms, e.g. disturbed trust or
hypersensitivity to social rejection, have become a major focus of BPD research. This article covers the current state
of knowledge and related relevant research goals. The first part presents a review of the literature. The second part
delineates important open questions to be addressed in future studies. The third part describes the research
agenda for a large German center grant focusing on mechanisms of emotion dysregulation in BPD.
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Borderline Personality Disorder (BPD) typically begins
during adolescence, shows a peak of symptom severity
during young adulthood, and appears to decline mod-
estly but steadily over the years. A large-scale prospect-
ive study conducted in the US [1], which is currently
viewed as the most valid, showed remission rates of 86%
after a 10-year follow-up (defined as a minimum of
4 years not meeting DSM-IV BPD criteria). These find-
ings have usually been interpreted as indicating that
most borderline patients attain a reasonably good overall
outcome 10 years after the index admission. However, a
more recent analysis of long-term social integration of
this population showed that only 50% of patients
achieved both remission from BPD symptoms and good* Correspondence: christian.schmahl@zi-mannheim.de
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unless otherwise stated.social and vocational functioning for a minimum of
2 years [2]. Good social functioning was defined as hav-
ing a score of at least 61 on the Global Assessment of
Functioning (GAF) scale. Of those who achieved recov-
ery, 34% later relapsed, resulting in a 10 years total
recovery rate of about 35%.
These long-term data are based on samples assessed in
the US starting in the 1990s, a time when development
of disorder-specific treatments was in its infancy. It
might be argued that the relatively low recovery rates
are due to a lack in specific psychiatric care manage-
ment. Within the last decade, a number of specific psy-
chosocial treatments with evidence of both effectiveness
and efficacy have been developed (for overview, see [3]),
and most of these treatments show medium to large ef-
fect sizes in the reduction of typical borderline behavior
or psychopathology. However, social integration of BPD
patients continues to be problematic: up to 50% of treated
patients have a GAF score lower than 60, indicating per-
sistent serious social problems that may correspond to thel Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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pretation of these data is that social integration of patients
with BPD (and thus recovery) is impaired by factors
distinct from those targeted by the currently existing best
practice treatments. If so, this necessitates further research
into the underlying pathophysiology, which we propose
below may be linked to emotional dysregulation, and the
transfer of those findings into a new generation of psycho-
therapeutic interventions. We will describe central mecha-
nisms of BPD in the following; it should be noted that
these do not necessarily correspond to the Research
Domain Criteria suggested by the NIH.
Phenomenology of emotion processing in BPD
A confirmatory factor analytic study of BPD [4] revealed
three core domains of psychopathology: affective dysregu-
lation, interpersonal disturbances, and behavioral dysregu-
lation. Three recent large twin studies have all pointed to
a common pathway model with one highly heritable
general BPD factor [5-7]. The last two of these revealed
two additional common liability factors, mainly reflect-
ing affective and interpersonal dimensions. Currently,
there is an ongoing debate about the hierarchy of these
domains and their potential interactions [8]. From a
sociobiological point of view, most of the interpersonal
problems of BPD patients (such as rejection sensitivity,
difficulties in cooperation, and hostile behavior) can be
seen as being driven by dysfunctional emotion process-
ing. From a developmental point of view, aversive inter-
personal experiences (such as insecure primary care,
early loss, or sexual abuse) can be seen as leading to
dysfunctional social cognitions that induce problems in
emotion regulation. However, rather than discussing these
interactions as a chicken-and-egg problem, one can see
them as circular mechanisms. According to an established
model by Gross [9], emotion regulation in general includes
not only social assumptions and neural regulatory
mechanisms but also implicit action tendencies and
social interaction.
Experienced clinicians have long suggested affective
dysregulation as a core feature of BPD and a driving
force behind several serious dysfunctional behavioral
patterns [10-14]. Affective dysregulation is related to the
frequency with which patients use maladaptive strategies
to regulate affect [15] and predicts other BPD behaviors
[14], including suicidal ideation and suicide attempts
[16,17], maladaptive interpersonal behaviors, and impul-
sive coping behaviors [18] such as alcohol abuse [19].
Several recent empirical studies have confirmed these
clinically based observations. It has been demonstrated
that, under both daily life and experimental conditions,
BPD patients experience significantly more intense aver-
sive emotions, higher tension, and more volatility of mood
than do healthy controls [20-23]. In particular, ambulatoryassessment (AA), the favored assessment methodology for
acquiring data under natural conditions, has provided
insight into the phenomenology of affective instability that
is present in BPD. Several studies based on AA have
yielded consistent findings, revealing an overall height-
ened affective instability of patients with BPD compared
with healthy controls (for an overview, see [24]). It should
be stated that these patterns of affective instability do not
seem to be specific for BPD. As Santangelo and coworkers
[25] recently showed, similar patterns have been found in
samples of patients with posttraumatic stress disorder
(PTSD) or with binge eating disorder.
When it comes to distinct and specific emotions in
BPD, social emotions such as shame, guilt, disgust, and
the fear of social rejection seem to be the most import-
ant [26-30] (Domsalla M, Liebke L, Thome J, Haeussler
K, Bohus M, Lis S: Rejection Sensitivity and Symptom
Severity in Patients with Borderline Personality Disorder:
Effects of Childhood Maltreatment and Self-Esteem. In
Borderline Personality Disorder and Emotion Dysregula-
tion.; 2014. submitted). According to both clinical and
scientific perspectives, the experience of high levels of
aversive tension often engenders marked dissociative
symptoms, which in turn are related to hypoalgesia
[31,32]. Emotional learning may be largely inhibited
during dissociative states [33]. Dysfunctional emotion
regulation may lead to strong aversive tension in line
with dissociative experience, which in turn hinders
adequate emotional learning. There is strong evidence
that non-suicidal self-injury (NSSI), a phenomenon very
often observed in BPD, is mostly used to down-regulate
these states of aversive tension or to stop dissociative
states [34-36].
Before we discuss the distinct mechanisms of dysfunc-
tional emotion processing in BPD, a short overview is
given on the current taxonomy of emotion processing in
general.
Basics of emotion processing
From a socio-psychological perspective, emotions may
be thought of as complex and evolved patterns of re-
sponse to both external and internal stimuli, providing a
fast situational interpretation along with a corresponding
action tendency. Emotion processing involves automatic
and intentional processes that influence the occurrence,
intensity, duration, and expression of emotions. There is
a wide spectrum of theories on how emotions can influ-
ence self-theory, identity, decision-making, social inter-
action, and even policy (for overview, see [37]).
Among others, Gross and colleagues [9,38] have
proposed a model of emotion regulation, based on
influential emotion theorists (e.g., [39-41]), which em-
phasizes the explicit or implicit appraisal of external or
internal emotional cues that trigger a set of experiential,
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model has already influenced treatment development for
BPD [42] and might serve as a current basis for research.
According to this model, emotions can be modulated
automatically or by either manipulating the input to the
system (antecedent-focused emotion regulation strategies)
or by manipulating the output of the regulation process
(response-focused emotion regulation strategies). Antecedent-
focused strategies include both implicit and explicit
strategies, such as situation selection or modification
and cognitive techniques (e.g., reappraisal, attention
deployment, or reframing of the situation), while
response-focused strategies include both implicit and
explicit strategies that can be subdivided into physio-
logical, cognitive, and behavioral processes.
However, Gross’s model does not consider the
potential role of emotional awareness or experiential
avoidance in emotion regulation. One could argue that
emotion regulation is mostly an automatic process, inde-
pendently of cognitive meta-awareness. On the other
hand, recent research has clearly demonstrated the po-
tential role of experiential avoidance in the pathogenesis
of psychic disorders. Experiential avoidance (EA) not
only includes any behavior that seeks to avoid, or escape
from, unwanted internal experiences or those external
conditions that elicit them, but also the pure awareness
of activated emotions [43]. Consequently, increasing
emotional awareness and emotion acceptance is cur-
rently seen as an important mode of action in psycho-
therapy in general and in BPD [44]. Schramm and
coworkers [45] showed that borderline personality fea-
tures were associated with significantly higher levels of
EA and difficulties in emotion regulation. Hierarchical
regression analyses showed that EA made a small but
significant incremental and independent contribution to
borderline features when added to a model that already
included difficulties in emotion regulation.
On a neuroanatomical level, the central areas involved
in the “emotion regulation circuitry” are thought to be
the dorsolateral and ventral areas of the prefrontal cor-
tex (including the anterior cingulate cortex [ACC]), as
well as the amygdala, the hippocampus, and the insula
[38]. It should, however, be stressed that these regions
fulfil several functions besides emotion regulation as
well. Ochsner and Gross suggested a psychobiological
circular model of emotion processing whereby emotions
are generated and modulated by interplaying macro- and
micro-circuits of “bottom-up” and “top-down” processes.
According to this model, central areas such as the amyg-
dala and the insula are involved in the evaluation of
external and internal stimuli regarding their emotional
valence. These stimuli are further processed in the
hypothalamus and in brain stem regions in order to acti-
vate autonomic and behavioral responses. In parallel,prefrontal and parietal cortical areas serve to allocate atten-
tion and to activate potential behavioral responses. Regula-
tory processes associated with areas of the lateral and
medial prefrontal cortex (MPFC) act to control and
modulate emotional activation, thereby covering typical
response-focused regulation strategies. Recent studies
suggest a regulatory hierarchy, whereby the dorsolat-
eral prefrontal cortex (DLPFC) and areas of the anter-
ior medio-prefrontal cortex modulate the cingulate,
which in turn modulates the amygdala and further sub-
cortical areas [46,47].
Importantly, these regulatory interactions are sensitive
to genetic variation in candidate genes that have been
reported to have an impact on personality as well as on
the risk for affective disorders and for which gene-
environment interactions with early childhood trauma
have been found [48-50]. Recent work has extended
these results to genome-wide significant risk variants for
severe psychiatric disorder [51] and has suggested a
common circuitry for emotion regulation and extinction
on which genetic and environmental risk factors
converge [52]. Regulatory processes can also be activated
by cognitive reappraisal, by changing attention, or by acti-
vating memories [50]. These cognitive strategies result in
an activation of lateral and medial prefrontal areas which,
in turn, involve the ACC and ultimately dampen emo-
tional arousal by attenuating the activity of the amygdala,
the mid-cingulate, and areas of the insula (for review, see
[50]). It should be stressed here that mechanisms of emo-
tion regulation are subject to genetic variation, to matur-
ing processes, and to inter-individual variation, as well as
to environmental risk factors such as early adversity or
poverty. Notably, during adolescence, there appears to be
a marked imbalance between increased sensitivity and
susceptibility of subcortical limbic areas to emotional
stimuli and not yet fully mature prefrontal areas. This
imbalance may account for the tendency towards high
emotional activation and impulsivity during adolescence
in general (reviewed in [53-55]).
Pathophysiology of emotion processing in BPD
This section will give an overview about findings in the
fields of genetics, structural imaging and spectroscopy,
functional imaging, pain processing and dissociation, as
well as neurochemistry.
Genetics of BPD
To date, the only studies on the genetics of BPD have
been small-scale and have yielded mostly inconsistent
results. A recent meta-analysis [56] found no direct role
of more than 20 investigated genetic variants in BPD or
BPD traits. No associations between BPD traits and
three serotonergic polymorphisms, two common poly-
morphisms of the serotonin transporter gene (SCL6A4),
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intron 2 VNTR, or the rs1800532 polymorphism of the
tryptophan hydroxylase 1 gene (TPH1) were found. All
studies, however, were conducted with very small sample
sizes, and to date there has been no published genome-
wide association study in BPD. On the other hand, a
genome-wide analysis and replication study of border-
line personality features [57] has been conducted in
three Dutch cohorts, which were comprised of a total
of 8426 participants. While no genome-wide signifi-
cant association was identified, the top findings which
could be replicated in the independent replication
sample were located in a region corresponding to SER-
INC5, a protein involved in myelination.
More promising avenues of study might use gene x
gene (e.g., [58,59] and gene x environment approaches
(e.g., [60] interactions). Interestingly, Distel and co-
workers [61] were able to demonstrate that the impact
of genetic factors on BPD features is lower in individuals
who have been victims of sexual abuse than in those
who have experienced other serious life events. Epigen-
etic research in BPD is also just beginning [62]. A pilot
study on mRNA gene expression demonstrated no ef-
fect of BPD per se, but an effect of dissociation on the
expression of genes involved in immune system regula-
tion as well as cellular signalling/second-messenger
systems [63].
Brain structure
(*In this paragraph, the following annotations for repli-
cation were included: A = replicated by more than one
research group, B = replicated by members within the same
research group, C = single study only without replication).
Among the most robust findings of structural imaging
in BPD patients are reduced volumes of the amygdala, the
hippocampus, the OFC, and the ACC [64,65] (A*). The
most recent meta-analysis, which incorporated 11 studies
with 205 BPD patients and 222 healthy controls, showed
an average decrease of 11% in the size of the hippocampus
and of 13% in the size of the amygdala [66]. Another
meta-analysis demonstrated that hippocampal reductions
are more pronounced in BPD patients who have co-
morbid PTSD. In those without PTSD, right but not left
hippocampal volumes were reduced [67]. More recently, a
whole-brain voxel-based morphometry (VBM) study in 60
patients with BPD confirmed volume reduction in the
hippocampus and amygdala as well as in the fusiform and
cingulate gyri [68]. A further study [69], which enrolled 30
BPD patients and 33 controls, found the gray matter of
patients with BPD to be reduced in the hippocampus but
increased in the hypothalamus compared to healthy par-
ticipants. Hypothalamic volume correlated positively with
the history of traumatization in BPD patients [70] (C*).
Another VBM study demonstrated that BPD and bipolardisorder have relatively distinct patterns of structural
alterations, with mostly fronto-limbic alterations in BPD
[71] (C*), however these data need replication within a
larger sample. Reduced volumes of the left ACC and the
right OFC (but not of the amygdala or hippocampus) were
detectable in a first study including adolescent BPD patients
(average age 17.4 years), and were found to correlate with
impulsivity and non-suicidal self-injury [72,73] (C*).
Specific differences were also found between criminal
offenders with either BPD or psychopathy [74] (C*).
The BPD offenders had lower volumes in the orbito-
frontal and ventromedial prefrontal cortex regions
subserving emotion regulation and reactive aggression,
while, for psychopathic offenders, the most significant
volumetric reductions were in the midline cortical
areas involved in the processing of self-referential in-
formation and self-reflection.
Ruesch and coworkers [75] (C*) used diffusion tensor
imaging (DTI) to investigate the relationship between
white matter integrity in the inferior frontal cortex and
several core symptoms of BPD, as well as to measure
the neuropsychological performance of BPD patients
with co-occurring attention-deficit-hyperactivity dis-
order (ADHD). Initial evidence was found for a pos-
sible relationship between core symptoms of BPD and
structural alterations of the white matter in the inferior
frontal cortex, as the average diffusion in the inferior
frontal cortex was related to affective dysregulation,
anger/hostility, and dissociation. However, no signifi-
cant group differences were detected in the DTI mea-
surements between BPD patients and healthy controls.
Additional analyses of this sample revealed abnormal-
ities of inter-hemispheric connectivity between both
sides of the anterior cingulate [76] (C*). Further DTI
studies showed decreased fractional anisotropy (FA) in
the genu and rostral areas of the corpus callosum as
well as in left and right prefrontal white matter [77]
(C*) in BPD adults and in the fornix in BPD adoles-
cents [78] (C*). New and coworkers [79] (C*) found de-
creased FA in the inferior longitudinal fasciculus and
other areas in BPD adolescents but not in BPD adults.
This most probably speaks for a transient disturbance
of connectivity in the development of BPD.
According to two MR spectroscopy study, the abso-
lute concentration of N-acetyl aspartate (NAA) in the
DLPFC is reduced by 19% in BPD patients, suggesting a
reduced cell density or a functional impairment within
this region [80] (C*). Compared with healthy controls,
subjects with BPD were found to have reduced NAA con-
centrations in the amygdala [81] (C*) and significantly
higher levels of glutamate in the ACC [82] (B*). In the latter
study, which could recently be confirmed in a new sample
(Ende, Cackowski, van Eijk, Sack, Sobanski, Krause-Utz,
Schmahl: Impulsivity and aggression are differentially
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concentrations in Borderline Personality Disorder and
Attention-Deficit-Hyperactivity Disorders. In preparation),
a positive correlation between glutamate concentration
and self-rated impulsivity was observed, as well as between
glutamate concentration and dissociation scores.
Neurochemistry
Initial studies on the neurochemistry of BPD primarily
focused on the hypothalamic–pituitary–adrenal (HPA)
axis as well as on the serotonergic, glutamate, oxytocin,
and opioid systems.
HPA axis
Findings with respect to the HPA axis are inconsistent,
possibly due to confounding effects of co-occurring disor-
ders such as depression and PTSD and small sample sizes.
While one study reported increased salivary cortisol levels
under daily life conditions [83], another found a signifi-
cantly reduced cortisol response to experimentally induced
social stress [84]. Notably, in this study, the reduced cortisol
response was not paralleled by reduced ACTH secretion,
which might suggest a stress-associated hypo-activity of the
adrenal cortex. A similar hypo-activity in response to the
Trier Social Stress Test (TSST) was found in adolescents
with NSSI, nearly half of whom fulfilled diagnostic criteria
for BPD [85]. In contrast to healthy controls, cortisol
administration enhanced rather than impaired memory
retrieval in BPD patients [86], which is similar to the effects
it has on PTSD patients [87].
Serotonin
This neurotransmitter system has important regulatory
functions in frontro-striatal circuits, and dysfunctions
which are considered to be important predictors for im-
pulsive behavior [88,89]. Subjects with impulsive and ag-
gressive behavioral tendencies were consistently found
to have reduced cerebrospinal fluid (CSF) concentration
of the metabolite 5-HIAA and reduced neuroendocri-
nological reaction to serotonergic agonists (e.g., D- or
D,L-fenfluramine, meta-chlorophenylpiperazine) [90,91].
Neuroimaging studies, each conducted in only 8 BPD
patients (e.g., [92,93]), have revealed altered metabolism
at baseline as well as in response to serotonergic
challenge in prefrontal regions including the ACC. SSRI
treatment (fluoxetine 20 mg/day) normalized prefrontal
cortex dysfunction in impulsive-aggressive BPD patients
in one study. [94].
Oxytocin
As a key mediator of trust behavior, the neuropeptide
oxytocin (OT) is involved in attachment and pro-social
behavior [95]. Furthermore, it has been shown that OT
modulates stress responses, especially in social contexts,and may be affected by early life adversity [96]. Parents
reporting greater parental care showed higher plasma
OT, low-risk CD38 alleles, and more physical contact
with their infants [97]. On a neurobiological level, there
is rising evidence that the application of OT might at-
tenuate the response of the amygdala to emotional stim-
uli [98]. The specific circuit on which OT has an impact
is a convergence zone for genetic and environmental risk
[52]. Thus from a developmental as well as a neurobio-
logical point of view, it appears plausible that alterations of
the OT system might be involved in the pathophysiology of
BPD [99]. Correspondingly, Bertsch and coworkers [100]
reported decreased peripheral OT concentrations in female
BPD patients, which negatively correlated with severity of
early traumata. Interestingly, a pilot study [101] found that
intra-nasal application of OT impaired trustful expectations
in BPD subjects, showing that while the OT system seems
to be disturbed in BPD, a simple substitution of the neuro-
peptide may not fix the problem. Bertsch and coworkers
[102] found a normalization of abnormal behavioral and
neuronal patterns after intranasal OT application while BPD
patients were scanning angry faces, suggesting that OT may
decrease threat hypersensitivity in this group of patients.
Opioids
Attenuated pain perception and the lack of effective
emotion regulation in BPD implicate a potential dys-
function of the endogenous opioid system [99,103]. BPD
patients with NSSI behavior were found to have signifi-
cantly lower levels of CSF β-endorphin and met-
enkephalin when compared with a non-NSSI BPD group
[104]. A PET study [105] found that under neutral con-
ditions, BPD patients compared to controls showed
greater regional μ-opioid receptor availability bilaterally
in the orbitofrontal cortex, caudate, nucleus accumbens,
and left amygdala but lower μ-opioid receptor availabil-
ity in the posterior thalamus; whereas during emotion
induction (sadness), they showed greater activation of
the endogenous opioid system in the pregenual anterior
cingulate, left orbitofrontal cortex, left ventral pallidum,
left amygdala, and left inferior temporal cortex.
Brain function and networks
(*In this paragraph, the following annotations for replica-
tion were included: A = replicated by more than one re-
search group, B = replicated by members within the same
research group, C = single study only without replication).
The cerebral processing of emotional stimuli in BPD
patients has been investigated in several PET and fMRI
studies. One study [106] found bilateral amygdala hyper-
activity in BPD patients while viewing emotionally aver-
sive pictures. This finding has been repeatedly replicated
with elevated amygdala responses to neutral pictures
as well [107-110] (A*). A recent finding of decreased
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sented stimuli is consistent with the clinical observation
of abnormally strong and long-lasting reactions to emo-
tional cues [111] (C*). Functional imaging studies using
cues or scripts to induce BPD-specific characteristics are
indicative of disturbed functioning in prefrontal regions.
For instance, script-driven induction of traumatic events
or of social separation in traumatized female BPD pa-
tients and traumatized women not meeting BPD criteria
resulted in a lower activation of both the ACC and the
OFC in the former [112,113] (B*). Studies on functional
correlates of response inhibition have yielded further
evidence for functional impairments of prefrontal areas,
notably of the DLPFC, the rostral ACC, and the OFC
[114] (C*). Minzenberg and coworkers [115], using an
implicit affect regulation task (responses to threatening
vs. neutral faces), demonstrated specifically enhanced
neural activation of the right amygdala in BPD along
with attenuated activations of the rostral ACC. In
response to an explicit affect regulation task based on
reappraisal strategies, OFC hypoactivation, in addition to
insular hyperactivation, was found, while negative emo-
tions were down-regulated [109] (C*). In a study that
used attentional distraction as a further regulation task,
BPD patients were shown to exhibit higher left-sided
amygdala activation than healthy controls [116] (C*).
Reduced connectivity between the OFC and the amygdala
in BPD patients was reported by New and coworkers
[117] (C*). Interestingly, in a pilot study, successful psy-
chotherapy was found to be paralleled by normalization in
the amygdala response as well as in prefrontal top-down
areas [118] (B*). These findings were recently corrobo-
rated in a larger controlled trial (Schmitt, Niedtfeld,
Winter, Herpertz, Schmahl unpublished observations). A
recent meta-analysis of fMRI studies across different
stimulation methods revealed greater activity in the
insula and reduced activation in the subgenual ACC and
DLPFC in BPD patients as compared to controls [119]
(A*).
Pain processing and dissociation
As already mentioned, reduced sensitivity to pain (hy-
poalgesia) and a close relationship between stress and
hypoalgesia have been consistently reported in BPD pa-
tients [120-124]. The sensory-discriminative component
in pain processing does not appear to be disturbed, but
abnormalities have been detected for affective pain pro-
cessing. More specifically, a deactivation of the amygdala
has been found during pain induction in BPD patients
[122,125]. A modulation of the affective pain component
in BPD patients by the well-known COMT val158met
polymorphism has been demonstrated [126], however
this findings needs replication. Furthermore, higher BPD
symptom severity and trait dissociation were associatedwith an attenuated signal decrease of the default mode
network in response to painful stimulation, and patients
with BPD exhibited less posterior cingulate cortex con-
nectivity with the left DLPFC during painful stimulation
[127]. Preliminary evidence from recent studies indicates
specificity of reduced pain sensitivity, as no differences
in proprioception and exteroceptive sensitivity were
found [123,128]. Also, no differences between BPD pa-
tients and controls were found regarding interoception
in a task where participants had to observe and count
their own heartbeats [129].
In a study that tested the aspect of emotion regulation
by sensory stimulation, pain that was experimentally
induced by thermal stimuli was found to result in the at-
tenuation of amygdala hyperactivity induced by affective
pictures [108]. Functional connectivity analyses revealed
normal inhibitory connectivity between the left amygdala
and MPFC and between the right anterior insula and
DLPFC when negative pictures were combined with
painfully hot stimulation but not when they were com-
bined with non-painfully warm stimulation [130], sug-
gesting that there may be a specificity of painful stimuli
in the context of sensory emotion regulation in BPD.
Using incision-induced pain, which takes into account
tissue damage and thus provides a more valid model for
non-suicidal self-injury, a stress-reducing effect of an
incision in the forearm in terms of reduced subjective
arousal and increased heart rate variability could be
demonstrated [131]. These findings were recently repli-
cated in an fMRI study in which an additional restitution
of post-stress amygdala-mPFC coupling following inci-
sion was shown (Reitz, Kluetsch, Niedtfeld, Knorz, Lis,
Paret, Kirsch, Meyer-Lindenberg, Treede, Baumgaertner,
Bohus, Schmahl: Incision and stress regulation in bor-
derline personality disorder. neurobiological mechanisms
of self-injurious behavior. Submitted).
It has been suggested that dissociation constitutes an
emotional over-modulation mode that responds to the
experience of (traumatic) stress, as opposed to an
emotional under-modulation mode with predominantly
intrusive symptoms and that these two modes can be
segregated on a neurofunctional level [132]. In particu-
lar, over-activity of medial prefrontal brain regions with
concomitant limbic down-regulation is hypothesized to
underlie dissociative psychopathology. Corroboration of
these assumptions comes from several sources. In one
study, patients with high levels of dissociation were found
to have significantly lower startle responses compared to
those with low levels of dissociation [133], while another
study found that dissociation scores were negatively cor-
related with activity in the amygdala, insula, and ACC
during emotional distraction that took place while the
participants were performing a working memory task
[134]. Dissociative phenomena have some similarity with
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it might therefore be useful to expand the research on
these phenomena from nociception and pain processing
to the processing of body perception, which has been
shown to be altered in BPD [135] .
Interpersonal disturbances
Interpersonal disturbances have been central to charac-
terizations of BPD since the earliest descriptions of this
disorder [136]. In the last few years, clinically based
observations have been confirmed by empirical data that
support alterations of the social lives in BPD. Romantic
partnerships are characterized by high instability in the
form of frequent breakups and reconciliations accom-
panied by low marital satisfaction, high attachment inse-
curity, communication problems, a high level of physical
and psychological violence, and a tendency to choose
partners who also have mental problems [137-139]. Sev-
eral studies observed altered maternal behavior linked
with impaired social interaction behavior in the children
of BPD patients [140-142]. However, one should be care-
ful about generalizing these premature findings, which
are based on small and selective samples. In everyday
life, BPD patients often experience more unstable social
relations than healthy controls as well as fewer social
interactions and have sometimes been shown to use
maladaptive resources for social support within their
social network [143,144].
Social interaction in BPD
Social interaction problems have been investigated in
BPD using questionnaires and experimental approaches
that aim to measure behavior directly during natural or
standardized interaction situations [145]. Subjective assess-
ments in questionnaires point to BPD patients showing
highly variable and more extreme interaction behaviors,
which have been described as more hostile, more quarrel-
some, and less affiliative in nature [143,146]. However, it
must be noted that findings based on self-based or
observer-based ratings primarily reflect the perception of
a subject’s competence, which might differ from their
actual behavior during a social encounter.
In the last several years, an increasing number of studies
have applied experimental approaches that measure inter-
action behavior in standardized situations within distinct
social domains. Specifically, they have investigated dyadic
or triadic interactions in the context of social exclusion,
provocation of aggressive behavior, and the ability to display
trustful and cooperative behavior (for review, see [145]).
Social rejection during social encounters
Several studies have used a virtual ball-tossing game
called “cyberball” [147] to induce the experience of so-
cial rejection, which, together with intense fear of lossand abandonment, may constitute a central factor of
interpersonal relationships in BPD. In this game, the co-
players’ behavior is manipulated to mimic inclusion, ex-
clusion, or neutral control conditions, during which the
players act according to predefined rules; i.e., without
personal motivations. In recently published studies, BPD
patients were found to feel more excluded during the in-
clusion and neutral conditions [148-151]. The experience
of social exclusion evoked especially intense negative emo-
tions such as contempt, resentment, and anger, which
were focused on others [150]. These findings suggest that
the awareness of social exclusion and the resulting
emotional reactions in BPD patients differ from those of
healthy individuals. It is worth emphasizing that this
seems to be true not only during the experience of social
rejection but also during the inclusion and neutral situa-
tions. A recent fMRI-study linked these alterations to a
lack in the modulation of activation in brain regions such
as the insula and the precuneus depending on the nature
of the social encounter [151].
No studies have yet addressed how BPD patients
cope with the experience of social rejection, such as
whether they tend to punish excluders or engage in
self-protective strategies, as healthy individuals have
been shown to do [152,153]. Such studies may provide
insight into the mechanism of dysfunctional social
interaction behavior and may constitute the basis for
the development of specific therapeutic intervention
strategies.
Social-cognitive information processing
Social interaction behavior is based on a multitude of
social cognitive processes, including the ability to
recognize emotions or intentions in social partners. An
increasing number of studies have confirmed that these
processes are affected in BPD, although the exact nature
of these alterations is still under debate. Studies on the
decoding of facial expressions suggest that BPD patients
show a heightened sensitivity to negative emotional cues
[154-157]. However, other studies have shown impair-
ments in detecting and labeling emotions for both nega-
tive and positive valent emotional expressions [158-162].
These heterogeneous findings point to the need to in-
vestigate which factors, such as social and non-social
stress, emotion regulation abilities, dissociative symp-
toms, and the necessity of coordinating these functions
with others in order to guide social interactions,
modulate emotion recognition in BPD [163]. Empirical
findings point to a social cognitive bias [164]. For ex-
ample, Staebler and coworkers found that experimen-
tally induced social rejection led to a negative bias for
perceived social participation [165], while Barnow and
coworkers [146] found that BPD patients have an inter-
pretational bias which leads them to assume that
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workers [166] found a bias for recognizing angry facial
expressions in ambiguous faces, a finding that was re-
cently replicated in a larger sample (Izurieta, Bertsch,
Herpertz unpublished). These data fit with studies that
investigated trust and cooperation in exchange games
established in behavioral economy. On a behavioral
level, King-Casas and coworkers [167] used a multi-
round trust game to demonstrate that BPD patients
showed less generous behavior than healthy controls,
leading to a breakdown in cooperation over the course
of the interaction. Similarly, Unoka and colleagues
[168] found that BPD patients failed to develop trust in
an interaction partner during a multi-round trust game
when they did not receive feedback about their part-
ner’s behavior. These experimental data fit with the
concept of BPD as a disorder of “mentalization”, which
gave rise to the development of “Mentalization Based
Therapy” – a BPD-specific psychosocial treatment
which has proven to be effective [169,170].
The term “mentalization” is derived from theory of
mind, and concerns a complex cognitive and affective
understanding of self and others and enables individuals
to navigate effectively in the social world. However,
while the concept of mentalization is a useful heuristic
approach, it has been criticized as being too broad and
multifaceted to be operationalized as a marker for
specific BPD pathology [171]. An increasing number of
experimental studies aim to precisely measure different
components of mentalizing and its behavioral and cere-
bral alterations in BPD [163,172-176]. In the future,
these findings may allow identification of the compo-
nents of mentalizing that are altered in BPD and, as a
consequence, lead to further refinement of theoretical
concepts and corresponding therapeutic interventions.
Animal models
Animal models of neuropsychiatric disorders are a valu-
able tool and an indispensable part of neurobiological
and psychiatric research that might even have direct
relevance as biomarkers for clinical conditions. It is
often very difficult to determine causal relationships
between a given symptom and pathological alterations
or contributing factors in clinical studies, but animal
models enable the examination of direct causal relation-
ships between behavioral and neurobiological abnormal-
ities. The detailed neuropathology and the etiology of
BPD are very complex and are only partially understood;
hence, valid animal models for BPD are urgently needed
and might offer crucial insights into the understanding
of basic neurobiological processes. However, the develop-
ment of suitable animal models of psychiatric disorders
poses major challenges [177,178]. Generating a valid and
potentially holistic animal model requires profoundknowledge of the etiology, pathogenesis, and pathophysi-
ology of a given disorder, and this detailed knowledge is
not available for many neuropsychiatric conditions.
Multiple and varied causal factors may induce similar
phenotypes [177], raising further complications.
The difficulties in establishing valid animal models in
neuropsychiatric research become particularly apparent
in the study of personality disorders, which are associ-
ated with ways of thinking and feeling about the self and
others that significantly and adversely affect how an in-
dividual functions in many aspects of life. Many of these
features are uniquely human and can only be inferred
with strong limitations in rodent models. Of the core
behavioral traits of BPD, only some sub-aspects, such as
emotional reactivity toward aversive/appetitive events,
impulsive behavior, pain processing, social competence,
and social needs (e.g., social recognition, social trust,
and the incentive value of social contact), can be assessed
with adequate face validity in rodents (e.g. [179-181]). In
particular, an aberrant social endophenotype can be
modeled and examined with high validity in laboratory
rodents (especially in rats) since rats and mice are highly
social, have complex social structures, and express a rich
repertoire of behavior patterns used for social recogni-
tion, affiliation, sex, and aggression [179,182].
Recently, a novel rat model was established for social
rejection in order to assess the acute and long-term con-
sequences of such adverse peer-experiences in adoles-
cence at both the behavioral and the molecular level
[183]. Since BPD patients often show an augmented sen-
sitivity toward social rejection [184], this model is also of
relevance for BPD research. The model is based on spe-
cific social requirements of adolescent rats, which spend
more time interacting with peers than do younger or
older animals. These peer-directed activities (mostly so-
cial play) have a considerable incentive value [185] and
are crucial for the development of social competence
[186]. In order to model social rejection, adolescent rats
of the playful Wistar strain were paired with either a
same-strain partner or a less playful Fischer344 strain
rat, which is an inadequate social partner for a Wistar
rat. Pairing with such an inadequate social partner
throughout adolescence was found to decrease later ad-
equate playful peer-interactions for Wistar rats without
depriving the animals of normal social contact. In the
long-term, these manipulations were found to increase
the pain threshold and emotional reactivity in these ani-
mals and to concomitantly induce alterations in cortico-
sterone release and aberrations in the endocannabinoid
system in the amygdala and the thalamus [183].
Conclusions
Clinical, phenomenological, and experimental findings
are evidence that emotion dysregulation and maladaptive
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bances of emotion processing typically translate into
dysfunctional expectations and interpretations in the
context of social interactions, and vice versa. On a neu-
roregulatory level, this could be manifested through
disturbances of the hierarchically modulated prefrontal
and prefrontal-amygdalar control circuits. Consequences
of these dysregulations include intense aversive tension
(which often leads to reduced executive functioning),
temporary disruption of integrative psychic functions
(dissociation), and the activation of learned maladaptive
coping strategies. From an interpersonal perspective, the
most robust findings are dysfunctional interpretation of
social cues, hyper-mentalization, problems with coaxing,
and hypersensitivity to social rejection and threat. Each
of these dysfunctional social cognitions is closely linked
to the emotional system, resulting in intermittent experi-
ences of intense fear of abandonment, social rejection,
and a strong desire for unconditional love.
Where do we go from here?
As shown above, the model of close interaction between
emotion dysregulation and disturbed social cognition in
BPD has been corroborated by a multitude of experi-
mental findings during the last decade. However, im-
portant questions still remain. First, we should clarify
which of these findings can be identified as prototypical
BPD-specific alterations and which can be better cha-
racterized as secondary “scars” of life-long chronic
stress, medication, or substance abuse. Consequently, we
should widen our scope beyond the limits of acute psy-
chopathology. Within this context, we should clarify
which of the disturbances observed in adult BPD pa-
tients can be traced back to adolescence. Subtle neuro-
biological alterations might be detectable already in
childhood and reveal themselves more strongly in
adolescence and early adulthood. Second, as most of the
previously published studies did not include clinical
controls, we need to establish to what extent psychobio-
logical alterations are specific to BPD. Third, the vast
majority of studies has been conducted in female BPD
patients, although field trials suggest that males may be
equally affected. Fourth, current evidence does not allow
for a conclusive interpretation of differential distur-
bances of neural sub-components involved in emotion
processing and social interaction. Finally, the promising
attempts to establish animal model for BPD pathology
should be continued. In the following sections, we
delineate some shortcomings in particular domains of
research.
Pathogenesis and life course
While the pathogenesis of BPD is not yet fully under-
stood, most researchers favor a model that postulates aninterplay between genetic predisposition and psychosocial
stress during childhood and adolescence. Several studies
support that sexual, physical, and emotional traumata
manifesting themselves through intense social rejection
sensitivity play an important role in the development of
BPD [187,188]. It is unclear whether and how these
experiences translate into alterations of neural systems on
a neurochemical, functional, and morphological level and
ultimately result in disturbed emotion processing or to
what extent certain neurobiological characteristics are vul-
nerability factors for this course and predate the problems
in emotional processing. This question could be causally
addressed with an adequate animal model. Although some
small-scale association studies have been conducted, there
is a lack of conclusive data on the potential role of genet-
ics in the development of BPD. This is partly due to the
complex interplay of different mechanisms. In particu-
lar, progress in genetic research is hampered by a lack
of well-defined endophenotypes, i.e., traits with a
neurobiological substrate that persist after remission
from acute psychopathology [189].
Another field that still contains many unanswered
questions pertains to the course of BPD. Evidence from
longitudinal studies points to a rapid reduction of the
number of fulfilled BPD criteria per individual within a
few years, with remission rates of up to 99% at 16-year
follow-up [6,190]. However, this might be misleading
since longitudinal studies have also demonstrated that
levels of psychosocial impairment do not significantly
decline, and that “temperamental” symptoms of BPD
such as dependency and anger are more persistent over
time [190], even after formal remission according to
diagnostic criteria has been reached. A cross-sectional
comparison of younger (18–25 years) and older (>45 years)
BPD patients showed that, although the prevalence of
individual symptoms such as impulsivity, suicidal behavior,
and affective instability is lower in older patients, the two
age groups are strikingly similar in terms of the average
number of fulfilled criteria, Axis I co-morbidities, and
functional impairment [192].
Emotion processing and neuroimaging
As described above, several small-scale studies have
tested the reactivity of BPD patients to different emo-
tional stimuli such as aversive pictures or faces. Also, re-
cent studies have begun to measure emotion regulation
by, for example, combining aversive stimuli with re-
appraisal or sensory stimulation. However, a comprehen-
sive analysis of an emotion (dys)regulation network in
BPD is lacking. Also lacking are studies that compare
different types of emotion regulation paradigms within
the same individuals, as well as studies that investigate
the influence of treatment (e.g., psychotherapy) on mea-
sures of emotion regulation.
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volumetric and spectroscopic results is difficult for sev-
eral reasons. Study samples have often been quite small
and have contained subjects with various co-morbidities.
Methodological differences between the studies need to
be considered, including a lack of differentiation of func-
tionally different subregions within the amygdala, the
ACC, and the OFC, as well as differences with respect to
field intensities and measurement reports (including
voxel size). Furthermore, many studies have included pa-
tients who were being treated with psychotropic medica-
tions, some of which are thought to have a substantial
impact on structural alterations. None of the studies
conducted so far has been able to find links between
volumetric findings and psychopathologically relevant
disturbances of emotion regulation.
Social interaction
Social interaction can be described as a dynamic se-
quence of actions between individuals during which the
behavior of one participant is continuously modulated
by the past actions and anticipated future actions of an-
other. Early studies suggested that the objective behav-
ioral and neurobiological description of this interaction
behavior allows for a new perspective on interpersonal
dysfunctioning in BPD. However, the number of studies
that use such an approach is still very small, and it is un-
known how their data fit with findings from self-based
and observer-based questionnaires that provide informa-
tion on how interaction behaviors are subjectively per-
ceived. Furthermore, a successful social encounter is
based on the integration of a multitude of social cogni-
tive processes, and a dysfunction of any of these may
lead to interpersonal disturbances. Although much at-
tention has been focused in the past on the investigation
of impairments of single social cognitive processes in
BPD, it is still unknown to what extent these described
alterations contribute to the dramatic problems in the
social lives of these patients. Thus, future studies need
to manipulate these processes experimentally in the con-
text of interactions in order to gain further insight into
the mechanisms of impaired interpersonal relations and
to enable the design of specific therapeutic intervention
strategies.
Animal models
Animal models, such as the Wistar/Fischer rat model
for social interaction described above, have the poten-
tial to shed further light on the basic neurological cir-
cuits and processes involved in rejection experiences
during adolescence. Rodent models addressing discrete
symptomatic aspects of BPD are quite useful; however,
to date, no holistic animal model has acounted for the
etiopathology, developmental aspects, pathogenesis,and complex symptomatology of the disorder. Al-
though the detailed etiology of BPD is still only par-
tially understood, a history of early aversities appears
to be closely connected to BPD (for review, see
[188,193,194]). Social experiences throughout the life
span may interfere with gene expression, brain deve-
lopment, and behavior, and it has been shown that
these influences have a particularly profound effect
during early development. In mammals, mother-infant
interactions are the primary source of tactile stimula-
tion for the developing offspring. These stimulations
influence not only physical growth but also various
neurodevelopmental processes [195-198], and labora-
tory rodents and nonhuman primates have shown that
variances in maternal care behavior induce lasting
neurobiological changes and affect offspring pheno-
type (for review, see [197,198]).
A research agenda for BPD and ED
In our view, the overarching aim of BPD research over
the next ten years should be to elucidate central patho-
mechanisms of emotion processing and social inter-
action in BPD parallel on the subjective, behavioral, and
neurobiological levels. Ultimately, the clarification of
these central pathomechanisms should improve strat-
egies for primary and secondary prevention and help to
optimize assessment and treatments on both a psycho-
therapeutic and a pharmacotherapeutic level. The first
step should be for researchers to investigate central
pathomechanisms (disturbed emotion processing and its
implications on social interaction) with respect to BPD
specificity, age dependence, gender dependence, and
long-term stability beyond remission of acute BPD
symptomatology. The second step should be to seek
validation of identified key mechanisms as potential
endophenotypes and to use these to tailor specific
therapeutic interventions.
One approach could be to focus on core psychobio-
logical mechanisms in the complex psychopathology of
BPD, and to investigate disturbed emotion processing in
various facets and at different levels. Some of these
mechanisms could potentially be used to define endo-
phenotypes, which should be closer to the site of the
primary causes (whether genetic or environmental) than
to the diagnostic category of BPD [199]. According to
one view [200], endophenotypes for mental disorders
are, among other criteria, primarily state-independent, i.
e., they manifest themselves whether or not the illness is
active. This view also suggests that endophenotypes are
related to the development of the disorder and do not
mimic long-term consequences or secondary manifesta-
tions of co-occurring Axis I disorders. Including remit-
ted patients and adolescent patients in research projects
could address these issues.
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research is that most studies have been carried out by
relatively small teams, which unavoidably results in
mono-methodological approaches. A multidisciplinary
cooperation would enable the integration of morpho-
logical, functional, endocrinological, and neuropsycho-
logical paradigms and measurement methods. We have
therefore started a large collaborative research program,
recently funded by the German Research Foundation as
a center grant, which may serve as an example of how
to transfer a research agenda into a multifaceted and
translational program. The central aim of this program,
titled “Clinical Research Unit (CRU): Mechanisms of
Disturbed Emotion Processing in Borderline Personality
Disorder”, is to break down the emotion processing and
interactive problems of BPD on a psychobiological level
and to elucidate the underlying mechanisms. The re-
sults will be used to fine-tune and expand currently
existing psychosocial treatments and to develop innova-
tive pharmacological approaches. The following pre-
sents an overview of the CRU and delineates its major
aims and methods.
The CRU consists of nine individual projects (see
Figure 1). Projects P1 to P5 focus on psychophysio-
logical and neural parameters related to disturbed so-
cial interactions and their implications for emotion
regulation, as follows:
 P1 investigates behavioral and neurobiological
patterns in response to experimentally induced
social exclusion in acute adult and adolescent BPD
patients and in remitted adult patients. In oneFigure 1 Overview of the mechanisms and projects of the CRU related t
`sub-project, a virtual reality paradigm is used to
induce the experience of group rejection gradually.
In a second sub-project, an established rejection
paradigm (cyberball) is examined under fMRI
conditions.
 P2 comprises two experimental fMRI paradigms and
an electrophysiological paradigm, comparing acute
adult and adolescent BPD populations and a
remitted adult BPD population to healthy controls
and a clinical comparison group of PTSD patients. It
investigates behavioral and neural correlates of BPD
patients’ hypersensitivity to social threats and what
the implications of the tendency to respond with
approach or avoidance. Another issue concerns the
aggressive and auto-aggressive manifestations of
anger, a prominent feature in BPD. Additionally, this
project is the first to systematically consider gender
effects in BPD by including male participants.
 P3 stems from the findings of King-Casas and
coworkers [167] that shows BPD patients’ substantial
deficits in establishing trust with cooperation partners.
This topic is being systematically evolved by using the
recently developed method of “hyperscanning” with 2
identical audio-visually linked MRI scanners. This
methodology allows investigation of dysfunctions in
cerebral regions that are related to basic interpersonal
interaction and trust and of the ramifications of these
dysfunctions on a behavioral level.
 P4 develops an animal model with face validity and
construct validity regarding aspects of the etiology
and symptomatology of BPD by modulating early
social relationships and social interactions in juvenileo social interaction (left) and emotion processing (right).
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symptoms of BPD such as emotion dysregulation,
pain sensitivity, and impulse control. The possible
lasting consequences of these manipulations on
social, emotional, and motivational behaviors are
then assessed at different points in life. In order to
achieve face-validity for BPD symptomatology, pain
perception and stress reactivity are tested. Further-
more, neurobiological alterations that might underlie
behavioral changes (e.g., alterations of the HPA axis,
the endogenous opioid system, and the endocanna-
binoid system) are analyzed in order to strengthen
the construct validity and possibly in order to lead
to pharmacological intervention strategies. A current
research aim is to examine behavioral and molecular
consequences of differences in maternal care in the
context of BPD in laboratory rats. In a later step,
these early modulations of mother-infant interac-
tions will be combined with our adolescent social
rejection model in order to study potential additive
effects of these two adverse social modulations
during different developmental periods.
 P5 develops a treatment module designed to
specifically improve the regulation of social
emotions and interactions of BPD patients, which
will be integrated as a further component of
Dialectical Behavior Therapy (DBT). It aims to
improve adequate interpretations within the social
context, mentalization processes, and the building of
trust and cooperation.
Projects P6 to P9 focus on neurobiological parame-
ters of disturbed emotion processing that are primarily
located on an intra-psychic (i.e., non-social) level, as
follows:
 P6 expands the converging findings on disturbed
pain processing and altered body perception in BPD
patients, as well as investigating potential
disturbances of multisensory interaction. One of its
major goals is to discriminate between chronic traits
and disturbances resulting from acute stress
(dissociation).
 P7 is based of fMRI findings of amygdala
hyperreactivity in response to emotional cues in
BPD patients. This project expands these findings,
and investigates the time course of the blood
oxygenation level-dependent (BOLD) response in
different brain regions. In a second step, innovative
neurofeedback training for BPD using real-time
fMRI is established. We assume that it will be
beneficial to train patients to control/monitor their
neural activity, e.g., by down-regulating limbic
hyperactivity. P8 investigates an emotion regulation strategy
frequently used by BPD patients that involves
self-inflicted tissue injury. In one sub-project, the
affective components of tissue-damaging and non-
tissue-damaging pain are investigated. In a second
sub-project, following stress induction, incisions will
be applied while psychophysiological, neuronal, and
neurochemical parameters of emotion regulation are
assessed. It is hypothesized that reduction of stress
levels will be stronger following tissue-damaging
when compared to non-tissue-damaging pain.
 P9 uses spectroscopy to assess glutamate and GABA
metabolism in the ACC and also considers the
impact of acute stress on executive functions in
BPD.
Overall, more than 1000 potential participants are
screened, and approximately 300 patients with current
or remitted BPD are included in one or more of the above-
mentioned projects. Patients are screened and allocated to
the individual projects via a central core project which also
conducts diagnostic assessments. Of course, this research
program can only cover some areas that are of relevance in
the field of BPD. Besides this program, other aspects of re-
search certainly deserve more attention in the field of BPD,
e.g. large longitudinal cohort studies or genome studies.
However, with this ambitious research program, we hope to
answer several of the open research questions described
above and to be able to pave the way for tailoring individu-
alized treatments for patients with BPD.
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